Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation

Journal of Perinatology

Volumn 29, Issue 11, 2009, Pages 731-737

  Davis, E P ^a,b   Waffarn, F ^b   Uy, C ^b   Hobel, C J ^c   Glynn, L M ^a   Sandman, C A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Division of Maternal Fetal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE;

ARTICLE; BIRTH WEIGHT; BODY HEIGHT; BODY SIZE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; INFANT; MALE; OUTCOME ASSESSMENT; PREMATURE LABOR; PRENATAL CARE; PRENATAL DRUG EXPOSURE;

ADULT; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; BIRTH WEIGHT; FEMALE; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; MALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; ULTRASONOGRAPHY, PRENATAL;

EID: 70350769412     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.85     Document Type: Article

References (36)

1. NIH Consensus Development Conference. Effects of corticosteroids for fetal maturation and perinatal outcomes. Am J Obstet Gynecol 1995; 173: 253-344.
2. Crowley P. Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972-1994. Am J Obstet Gynecol 1995; 173: 322-355.
3. Steer P, Flint C. ABC of labour care: Preterm labour and premature rupture of membranes. Br Med J 1999; 318: 1059-1062.
4. Polyakov A, Cohen S, Baum M, Trickey D, Jolley D, Wallace EM. Patterns of antenatal corticosteroid prescribing 1998-2004. Aust N Z J Obstet Gynaecol 2007; 47(1): 42-45.
5. Moss TJ, Nitsos I, Harding R, Newnham JP. Differential effects of maternal and fetal betamethasone injections in late-gestation fetal sheep. J Soc Gynecol Investig 2003; 10(8): 474-479.
6. Johnson J, Mitzner W, London W, Palmer A, Scott R. Betamethasone and the rhesus fetus: Multisystemic effects. Am J Obstet Gynecol 1979; 133(6): 677-684.
7. Kutzler MA, Ruane EK, Coksaygan T, Vincent SE, Nathanielsz PW. Effects of three courses of maternally administered dexamethasone at 0.7, 0.75, and 0.8 of gestation on prenatal and postnatal growth in sheep. Pediatrics 2004; 113(2): 313-319.
8. Jobe A, Wada N, Berry L, Ikegami M, Ervin M. Single and repetitive maternal glucocorticoid exposure reduce fetal growth in sheep. Am J Obstet Gynecol 1998; 178: 880-885.
9. Johnson JW, Mitzner W, London WT, Sly DL, Lee PA, Khouzami VA et al. Long-term effects of betamethasone on fetal development. Am J Obstet Gynecol 1981; 141: 1053-1064.
10. Levitt NS, Lindsay RS, Holmes MC, Seckl JR. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 1996; 64(6): 412-418.
11. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 1998; 101: 2174-2181.
12. Moss TJ, Sloboda DM, Gurrin LC, Harding R, Challis JRG, Newnham JP. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Comp Physiol 2001; 281(3): R960-R970.
13. Bloom SL, Sheffield JS, Mcintire DD, Leveno KJ. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 2001; 97(4): 485-490.
14. Thorp JA, Jones PG, Knox E, Clark RH. Does antenatal corticosteroid therapy affect birth weight and head circumference? Obstet Gynecol 2002; 99(1): 101-108.
15. French N, Hagan R, Evans SF, Godfrey M, Newnham J. Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 1999; 180: 114-121.
16. Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: A randomised controlled trial. The Lancet 2006; 367: 1913-1919.
17. Thorp JA, Jones AM, Hunt C, Clark R. The effect of multidose antenatal betamethasone on maternal and infant outcomes. Am J Obstet Gynecol 2001; 184(2): 196-202.
18. Smith GCS, Smith MFS, McNay MB, Fleming JEE. First-trimester growth and the risk of low birth weight. N Eng J Med 1998; 339(25): 1817-1822.
19. Newnham JP, Moss TJ. Antenatal glucocorticoids and growth: Single versus multiple doses in animal and human studies. Semin Neonatol 2001; 6(4): 285-292.
20. Piazze J, Berretta AR, Cioccio D, Anceschi M. Neonatal length and cranial circumference are reduced in human pregnancies at term after antepartum administration of betamethasone. J Perinat Med 2005; 33(5): 463-464.
21. Oken E, Kleinman K, Rich-Edwards J, Gillman M. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3(6): 1-10.
22. Hadlock F, Harris R, Sharman R, Deter R, Park S. Estimation of fetal weight with the use of head, body and femur measurements - a prospective study. Am J Obstet Gynecol 1985; 151: 333-337.
23. Jobe AH, Newnham JP, Moss TJ, Ikegami M. Differential effects of maternal betamethasone and cortisol on lung maturation and growth in fetal sheep. Am J Obstet Gynecol 2003; 188: 22-28.
24. Wapner RJ, Sorokin Y, Thom EA, Johnson F, Dudley DJ, Spong CY et al. Single versus weekly courses of antenatal corticosteroids: Evaluation of safety and efficacy. Am J Obstet Gynecol 2006; 3(195): 633-642.
25. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005; 365: 1856-1862.
26. Shelton SD, Boggess KA, Murtha AP, Groff AO, Herbert WN. Repeated fetal betamethasone treatment and birth weight and head circumference. Obstet Gynecol 2001; 97(2): 301-304.
27. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: The role of the mother, placenta, and fetus. Endocr Rev 2006; 27(2): 141-169.
28. Drake AJ, Tang JI, Nyirenda MJ. Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. Clin Sci 2007; 113(10): 219-232.
29. Rose JC, Schwartz J, Green J, Kerr DR. Development of the corticotropin-releasing factor adrenocorticotropic hormone/ Beta-endorphin system in the mammalian fetus. In: Polin RA, Fox WW (eds). Fetal and Neonatal Physiology. W. B. Saunders: Philadelphia, USA, 1998, pp 2431-2442.
30. Winter SDW. Fetal and neonatal adrenocortical physiology, in Fetal and Neonatal Physiology In: Polin RA, Fox WW (eds). W. B. Saunders: Philadelphia, 1998, pp 378-403.
31. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997; 18(18): 378-403.
32. Austin MP, Leader L. Maternal stress and obstetric and infant outcomes: epidemiological findings and neuroendocrine mechanisms. Aust N Z J Obstet Gynaecol 2000; 40(3): 331-337.
33. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endo 1994; 105(2): R11-R17.
34. Brown RW, Kotolevtsev Y, Leckie C, Lindsay RS, Lyons V, Murad P et al. Isolation and cloning of human placental 11b-hydroxysteroid dehydrogenase-2 cDNA. Biochem J 1996; 313: 1007-1017.
35. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173 254-262.
36. Sloboda DM, Challis JRG, Moss TJ, Newnham JP. Synthetic glucocorticoids: antenatal administration and long-term implications. Curr Pharm Des 2005; 11(11): 1459-1472.